Part 3/9:
One of the most exciting aspects of China’s biotech outlook is the influx of skilled scientists returning to China. Under programs like the Thousand Talents Program, these scientists, previously employed by Western pharmaceutical firms, are being lured back to foster homegrown innovations. This repatriation of talent enhances the quality and scope of research in China and augments the nation’s capacity for home-grown drug development.